Changes in serum high mobility group box-1 protein and high-sensitivity C-reactive protein in patients with acute cerebral infarction and their clinical significance

Chinese Critical Care Medicine

Volumn 24, Issue 5, 2012, Pages 265-268

  Zhou, Ping ^a   Li, Ying Qiu ^b   Li, Wei Dong ^b   Han, Tong Shi ^b   Yang, Sheng Jin ^b   Yao, Yong Ming ^b   Zhang, Yang Ying ^b   Yu, Yan ^b  

^a INSTITUTE OF AVIATION MEDICINE   (China)

^b NONE

Author keywords

Cerebral infarction, acute; High mobility group box 1 protein; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN;

ACUTE DISEASE; ARTICLE; BLOOD SAMPLING; BRAIN CIRCULUS ARTERIOSUS; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERNAL CAROTID ARTERY; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; HMGB1 PROTEIN; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84862177743     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.05.003     Document Type: Article

References (23)

1. Basic Kes V, Simundic AM, Nikolac N, et al. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem, 2008,41:1330-1334.
2. Chang LT, Yuen CM, Liou CW, et al. Link between interleukin-10 level and outcome after ischemic stroke. Neuroimmunomodulation, 2010,17:223-228.
3. Qiu J, Xu J, Zheng Y, et al. High-mobility group box I promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke, 2010,41:2077-2082.
4. Tuttolomondo A, Di Raimondo D, Pecoraro B, et al. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis, 2010,213:311-318.
5. Song IU, Kim JS, Kim Yl. et al. Ralationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis, 2009,28:545-550.
6. Purroy F, Montaner J, Molina CA, et al. C-reactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand, 2007,115:60-66. (Pubitemid 44915500)
7. You L, Wang P, Lv J, et al. The role of high-sensitivity C-reactive protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation. J Huazhong Univ Sci Technolog Med Sci, 2010,30:648-651.
8. Azarpazhooh MR, Moharra N, Parizadeh SM, et al. Serum high-sensitivity C-reactive protein and heat shock protein 27 antibody titers in patients with stroke and 6-month prognosis. Angiology, 2010,61:607-612.
9. Makita S, Nakamura M, Satoh K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis, 2009,204:234-238.
10. Youssef MY, Mojiminiyi OA, Abdella NA. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Transl Res, 2007,150:158-163. (Pubitemid 47302968)
11. Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol, 2009,215:84-89.
12. Zhang J, Takahashi HK, Liu K, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke, 2011,42:1420-1428.
13. Muhammad S, Barakat W, Stoyanov S, et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci, 2008,28:12023-12031.
14. Hayakawa K, Qiu J, Lo EH. Biphasic actions of HMGBl signaling in inflammation and recovery after stroke. Ann N Y Acad Sci, 2010,1207:50-57.
15. Kim JB, Sig Choi J, Yu YM, et al. HMGBl, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci, 2006,26:6413-6421.
16. Ye X, Chopp M, Liu X, et al. Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats. Neuroscience, 2011,190:339-345.